These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32949729)

  • 1. Cytotoxicity comparison of 35 developmental neurotoxicants in human induced pluripotent stem cells (iPSC), iPSC-derived neural progenitor cells, and transformed cell lines.
    Kamata S; Hashiyama R; Hana-Ika H; Ohkubo I; Saito R; Honda A; Anan Y; Akahoshi N; Noguchi K; Kanda Y; Ishii I
    Toxicol In Vitro; 2020 Dec; 69():104999. PubMed ID: 32949729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative neurotoxicity screening in human iPSC-derived neural stem cells, neurons and astrocytes.
    Pei Y; Peng J; Behl M; Sipes NS; Shockley KR; Rao MS; Tice RR; Zeng X
    Brain Res; 2016 May; 1638(Pt A):57-73. PubMed ID: 26254731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating biokinetics and in vitro studies to evaluate developmental neurotoxicity induced by chlorpyrifos in human iPSC-derived neural stem cells undergoing differentiation towards neuronal and glial cells.
    Di Consiglio E; Pistollato F; Mendoza-De Gyves E; Bal-Price A; Testai E
    Reprod Toxicol; 2020 Dec; 98():174-188. PubMed ID: 33011216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rotenone exerts developmental neurotoxicity in a human brain spheroid model.
    Pamies D; Block K; Lau P; Gribaldo L; Pardo CA; Barreras P; Smirnova L; Wiersma D; Zhao L; Harris G; Hartung T; Hogberg HT
    Toxicol Appl Pharmacol; 2018 Sep; 354():101-114. PubMed ID: 29428530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards in vitro DT/DNT testing: Assaying chemical susceptibility in early differentiating NT2 cells.
    Menzner AK; Abolpour Mofrad S; Friedrich O; Gilbert DF
    Toxicology; 2015 Dec; 338():69-76. PubMed ID: 26498558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative performance analysis of human iPSC-derived and primary neural progenitor cells (NPC) grown as neurospheres in vitro.
    Hofrichter M; Nimtz L; Tigges J; Kabiri Y; Schröter F; Royer-Pokora B; Hildebrandt B; Schmuck M; Epanchintsev A; Theiss S; Adjaye J; Egly JM; Krutmann J; Fritsche E
    Stem Cell Res; 2017 Dec; 25():72-82. PubMed ID: 29112887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of developmental neurotoxicity induced by chemical mixtures using an adverse outcome pathway concept.
    Pistollato F; de Gyves EM; Carpi D; Bopp SK; Nunes C; Worth A; Bal-Price A
    Environ Health; 2020 Feb; 19(1):23. PubMed ID: 32093744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Pluripotent Stem Cells as Tools for Predicting Developmental Neural Toxicity of Chemicals: Strategies, Applications, and Challenges.
    Liang S; Yin N; Faiola F
    Stem Cells Dev; 2019 Jun; 28(12):755-768. PubMed ID: 30990109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of neurotransmitter release in human iPSC-derived neuronal/glial cells: a missing in vitro assay for regulatory developmental neurotoxicity testing.
    Cervetto C; Pistollato F; Amato S; Mendoza-de Gyves E; Bal-Price A; Maura G; Marcoli M
    Reprod Toxicol; 2023 Apr; 117():108358. PubMed ID: 36863571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining in vitro assays and mathematical modelling to study developmental neurotoxicity induced by chemical mixtures.
    Pistollato F; Carpi D; Mendoza-de Gyves E; Paini A; Bopp SK; Worth A; Bal-Price A
    Reprod Toxicol; 2021 Oct; 105():101-119. PubMed ID: 34455033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Ntera2 cells as a predictive in vitro test system for developmental neurotoxicity.
    Stern M; Gierse A; Tan S; Bicker G
    Arch Toxicol; 2014 Jan; 88(1):127-36. PubMed ID: 23917397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use.
    Aschner M; Ceccatelli S; Daneshian M; Fritsche E; Hasiwa N; Hartung T; Hogberg HT; Leist M; Li A; Mundi WR; Padilla S; Piersma AH; Bal-Price A; Seiler A; Westerink RH; Zimmer B; Lein PJ
    ALTEX; 2017; 34(1):49-74. PubMed ID: 27452664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurospheres as a model for developmental neurotoxicity testing.
    Fritsche E; Gassmann K; Schreiber T
    Methods Mol Biol; 2011; 758():99-114. PubMed ID: 21815061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurite outgrowth in human induced pluripotent stem cell-derived neurons as a high-throughput screen for developmental neurotoxicity or neurotoxicity.
    Ryan KR; Sirenko O; Parham F; Hsieh JH; Cromwell EF; Tice RR; Behl M
    Neurotoxicology; 2016 Mar; 53():271-281. PubMed ID: 26854185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DNT-EST: a predictive embryonic stem cell-based assay for developmental neurotoxicity testing in vitro.
    Hayess K; Riebeling C; Pirow R; Steinfath M; Sittner D; Slawik B; Luch A; Seiler AE
    Toxicology; 2013 Dec; 314(1):135-47. PubMed ID: 24096155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem Cell-Derived Immature Human Dorsal Root Ganglia Neurons to Identify Peripheral Neurotoxicants.
    Hoelting L; Klima S; Karreman C; Grinberg M; Meisig J; Henry M; Rotshteyn T; Rahnenführer J; Blüthgen N; Sachinidis A; Waldmann T; Leist M
    Stem Cells Transl Med; 2016 Apr; 5(4):476-87. PubMed ID: 26933043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based toxicity screening in human induced pluripotent stem cell-derived cardiomyocytes.
    Burnett SD; Blanchette AD; Grimm FA; House JS; Reif DM; Wright FA; Chiu WA; Rusyn I
    Toxicol Appl Pharmacol; 2019 Oct; 381():114711. PubMed ID: 31425687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do Induced Pluripotent Stem Cell Characteristics Correlate with Efficient In Vitro Smooth Muscle Cell Differentiation? A Comparison of Three Patient-Derived Induced Pluripotent Stem Cell Lines.
    Zhou Y; Kang G; Wen Y; Briggs M; Sebastiano V; Pederson R; Chen B
    Stem Cells Dev; 2018 Oct; 27(20):1438-1448. PubMed ID: 30153084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole genome microarray analysis of neural progenitor C17.2 cells during differentiation and validation of 30 neural mRNA biomarkers for estimation of developmental neurotoxicity.
    Attoff K; Gliga A; Lundqvist J; Norinder U; Forsby A
    PLoS One; 2017; 12(12):e0190066. PubMed ID: 29261810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods.
    Bal-Price A; Pistollato F; Sachana M; Bopp SK; Munn S; Worth A
    Toxicol Appl Pharmacol; 2018 Sep; 354():7-18. PubMed ID: 29476865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.